Body composition following gender affirming hormone therapy in transgender individuals. [PDF]
Kolla B, Kalra P.
europepmc +1 more source
4‐HBA upregulates NKIRAS2 levels, inhibiting the activation of the NF‐κB pathway and subsequently reducing the levels of neuroinflammatory markers. This modulation helps restore normal mood and behavior in hyperlipidemic conditions, providing a potential therapeutic strategy for managing hyperlipidemia‐associated depression.
Ying Zhang +7 more
wiley +1 more source
Subcutaneous Estradiol Pellets as Hormone Therapy in Menopause: Clinical Pharmacology, Patient Selection and Safety Considerations. [PDF]
Jacobsen L +4 more
europepmc +1 more source
Children with craniopharyngioma resection had better response to recombinant human growth hormone therapy than those with idiopathic short stature. [PDF]
Li T, Li C, Wang X, Nie M, Wu X, Mao J.
europepmc +1 more source
One-year changes in body composition and phase angle during feminizing gender-affirming hormone therapy: a longitudinal and comparative study. [PDF]
Avcı S +9 more
europepmc +1 more source
Comparison of speaking fundamental frequency between premenopausal and postmenopausal women with and without hormone therapy [PDF]
D'haeseleer, Evelien +3 more
core
Growth Hormone Therapy in Neurosecretory Dysfunction. [PDF]
Çetiner EB +6 more
europepmc +1 more source
Deficiency of anterior pituitary hormones in Noonan syndrome and its impact on response to growth hormone therapy. [PDF]
Basu R +10 more
europepmc +1 more source
Gender-affirming hormone therapy: Effect on semen quality and use of fertility preservation. [PDF]
Conflitti AC +7 more
europepmc +1 more source

